Research Archives

April 4, 2016 Changing the course: Parkinson’s disease research in 2016

By Patrik Brundin, M.D., Ph.D. Director, Center for Neurodegenerative Science The time has come to shift the paradigm on Parkinson’s disease. Never before have we…

March 30, 2016 New compounds may aid in development of targeted therapies for a rare pediatric cancer

GRAND RAPIDS, Mich. (March 30, 2016)—Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects…

March 8, 2016 Breakthrough discovery honored by leading scientific organization

GRAND RAPIDS, Mich. (March 8, 2016)—Van Andel Research Institute (VARI) Professor H. Eric Xu will receive the prestigious Hans Neurath Award in…

February 22, 2016 Promising respiratory drug focus of new clinical trial for Parkinson’s disease

GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus…

January 28, 2016 Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team

GRAND RAPIDS, Mich. (Jan. 28, 2016)—The first clinical trial to move forward as part of the Van Andel Research Institute–

January 26, 2016 Scientists identify potential “guardian” against neurodegeneration

GRAND RAPIDS, Mich. (Jan. 26, 2016)—Stopping disruptions in cellular “trash removal” brought on by errors in molecular marks on DNA may guard against neurodegenerative diseases…

January 14, 2016 Renowned neuroscientist Jeffrey H. Kordower expands his Parkinson’s research to Michigan

GRAND RAPIDS, Mich. (January 14, 2016)—Esteemed neuroscientist and leading Parkinson’s disease expert Jeffrey H. Kordower, Ph.D., of Rush University…

January 12, 2016 Dr. Stefan Jovinge accepts Stanford University School of Medicine consulting professorship

GRAND RAPIDS, Mich. (Jan. 12, 2016)—Van Andel Research Institute (VARI) and Spectrum Health’s Stefan Jovinge, M.D., Ph.D., has been appointed to a consulting professorship at…